Clinical Trial Update: A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating the long-term safety and tolerability of tolebrutinib in participants with multiple sclerosis, including Relapsing MS…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis
• Progressive Relapsing Multiple Sclerosis
• Relapsing Multiple Sclerosis

Drugs mentioned

• Tolebrutinib (tolebrutinib)

Snippet

Sponsor: Sanofi | Conditions: Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING